Abstract
Objective: To ascertain the cross-sectional association between cardiovascular autonomic dysfunction and arterial stiffness across glucose metabolism status. Research design and methods: We performed a cross-sectional analysis of participants of the Maastricht study. Cardiovascular autonomic function was based on heart rate variability (HRV) indices from 24-hour ECG recordings and summarized in z-scores for time and frequency domains. Aortic and carotid stiffness were assessed by carotid-femoral pulse wave velocity (PWV) and carotid artery distensibility (CD), respectively. We used multiple linear regression to study the associations and adjusted for demographic and lifestyle factors and a range of cardiovascular risk factors. We tested for effect modification of the associations by glucose metabolism status. Results: PWV and CD measures were available in 3673 and 1802 participants, respectively (median (25th; 75th percentile) age: 60 years (53; 66), 51% women, 20% type 2 diabetes by design. Participants with lower HRV had higher aortic stiffness. Per SD lower time-domain and frequency-domain HRV z-scores were associated with 2.8% (95% CI 2.1% to 3.4%) and 2.8% (95% CI 2.1% to 3.5%) higher PWV, respectively. Similar trends were observed for carotid stiffness, with 3.2% (95% CI 1.4% to 5.0%) and 3.1% (95% CI 1.2% to 5.0%) lower CD per SD lower time-domain and frequency-domain HRV, respectively. The magnitude of these associations was higher in groups with prediabetes and type 2 diabetes compared with those with normal glucose metabolism, with evidence of effect modification by glucose metabolism status (p value for interaction: <0.01 for prediabetes and <0.05 to <0.10 for type 2 diabetes, both compared with normal glucose metabolism). Conclusion: Cardiovascular autonomic dysfunction is associated with higher aortic and carotid stiffness, especially in people with dysglycemia.
Funding Information
  • Steno Diabetes Center Copenhagen (N/A)
  • NUTRIM School for Nutrition and Translational Research in Metabolism (N/A)
  • Steno Diabetes Center Aarhus (N/A)
  • The Dutch Ministry of Economic Affairs (310.041)
  • CARIM School for Cardiovascular Diseases (N/A)
  • European Regional Development Fund via OP-Zuid (N/A)
  • Health Foundation Limburg (N/A)
  • the Province of Limburg (N/A)
  • Novo Nordisk Farma B.V. (N/A)
  • EFSD/Sanofi European Diabetes Research Programme in diabetes associated with cardiovascular disease 2022 (N/A)
  • Stichting De Weijerhorst (N/A)
  • CAPHRI Care and Public Health Research Institute (N/A)
  • the Cardiovascular Center (N/A)
  • the Pearl String Initiative Diabetes (N/A)
  • Janssen-Cilag B.V. (N/A)
  • Stichting Annadal (N/A)
  • Sanofi-Aventis Netherlands B.V. (N/A)

This publication has 38 references indexed in Scilit: